Junfeng Zhu

机构：Chinese Academy of Sciences, Wenzhou Medical University, Zhejiang Cancer Hospital · ORCID：0000-0002-3040-6082

发表论文 43 篇 · 总被引 617 次 · h-index 13

代表论文

• Expert consensus statement on therapeutic drug monitoring and individualization of linezolid (2022 · Frontiers in Public Health · 被引 80)
• Multianalysis of 35 Mycotoxins in Traditional Chinese Medicines by Ultra-High-Performance Liquid Chromatography–Tandem Mass Spectrometry Coupled with Accelerated Solvent Extraction (2012 · Journal of Agricultural and Food Chemistry · 被引 76)
• Chemical profiling and antioxidant evaluation of Yangxinshi Tablet by HPLC–ESI-Q-TOF-MS/MS combined with DPPH assay (2017 · Journal of Chromatography B · 被引 58)
• Integrated Bioinformatics Analysis of Master Regulators in Anaplastic Thyroid Carcinoma (2019 · BioMed Research International · 被引 49)
• Ferroptosis: A novel therapeutic target of natural products against doxorubicin-induced cardiotoxicity (2024 · Biomedicine & Pharmacotherapy · 被引 38)
• Identification and experimental validation of mitochondria-related genes biomarkers associated with immune infiltration for sepsis (2023 · Frontiers in Immunology · 被引 38)